Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

— Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) reported financial results for the quarter and ended March 31, 2020. Full versions of the Company’s unaudited condensed interim consolidated financial statements and MD&A can be found on SEDAR at www.sedar.com. “In the first quarter and year to date, the benefits of Emerald’s significant restructuring andContinue reading “Emerald Health Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update”